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Attitudes of stakeholders in psychiatry
towards the inclusion of children in
genomic research
Anna Sundby1,2*, Merete Watt Boolsen3, Kristoffer Sølvsten Burgdorf4, Henrik Ullum4,
Thomas Folkmann Hansen2,5,6 and Ole Mors1,2
Abstract
Background: Genomic sequencing of children in research raises complex ethical issues. This study aims to gain more
knowledge on the attitudes towards the inclusion of children as research subjects in genomic research and towards
the disclosure of pertinent and incidental findings to the parents and the child.
Methods: Qualitative data were collected from interviews with a wide range of informants: experts engaged in genomic
research, clinical geneticists, persons with mental disorders, relatives, and blood donors. Quantitative data were collected
from a cross-sectional web-based survey among 1227 parents and 1406 non-parents who were potential stakeholders in
psychiatric genomic research.
Results: Participants generally expressed positive views on children’s participation in genomic research. The informants
in the qualitative interviews highlighted the age of the child as a critical aspect when disclosing genetic information.
Other important aspects were the child’s right to an autonomous choice, the emotional burden of knowing imposed
on both the child and the parents, and the possibility of receiving beneficial clinical information regarding the future
health of the child. Nevertheless, there was no consensus whether the parent or the child should receive the findings.
A majority of survey stakeholders agreed that children should be able to participate in genomic research. The majority
agreed that both pertinent and incidental findings should be returned to the parents and to the child when of legal
age. Having children does not affect the stakeholder’s attitudes towards the inclusion of children as research subjects
in genomic research.
Conclusion: Our findings illustrate that both the child’s right to autonomy and the parents’ interest to be informed are
important factors that are found valuable by the participants. In future guidelines governing children as subjects
in genomic research, it would thus be essential to incorporate the child’s right to an open future, including the
right to receive information on adult-onset genetic disorders.
Keywords: Child, Minors, Attitude, Whole genome sequencing, Ethics research, Mental disorders
Background
Genome sequencing, i.e., whole genome and whole
exome sequencing, has now become a widely used tool
in research, for example, in psychiatric genetic research.
However, genome sequencing generates huge amounts
of genomic information, and some of the information is
clinically useful. There is an ongoing debate regarding the
return of individual genetic research findings unrelated to
the condition under investigation [1–7]. The community
of clinical genetics refers to these types of results as
incidental findings [8]. Because incidental findings should
be expected as a part of genomic sequencing, other terms
as secondary findings, additional findings, and non-
pertinent findings have been suggested [8, 9]. However,
the increasing number of large-scale genomic research
projects and the inclusion of children in genomic research
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have made it important to continue the debate regarding
the return of individual genetic research findings.
Children are included in genomic research because
some disorders are childhood-onset [10]. For example,
to study genetic factors for attention deficit hyperactivity
disorder (ADHD) or autism spectrum disorder, blood
and buccal cell samples from children with ADHD and
autism spectrum disorder are often taken in the clinical
setting and used for research. Research on children can
also be done using already existing biological samples
stored in a biobank. For example, the Danish Neonatal
Screening Biobank holds archived blood samples from all
newborns in Denmark after screening for phenylketonuria
(PKU) and several other congenital diseases [11, 12]. The
dried blood spot samples from the neonates provide an
opportunity to use DNA from children in research on a
very large scale [13].
The ethical issues of including children in genomic
research differ from those raised when including adults
[10, 14, 15]. One of the biggest differences is that a third
party (the parent) must mediate the relationship between
the researcher and the research subject (the child) [10,
14, 16, 17]. Furthermore, young children do not have the
same capacity to understand the research information or
the implications of the findings. Common questions
related to involvement of children in genomic research
include the following: Should children be research
subjects at all? Should the findings be returned to the
child or to the parents? [5, 10, 14, 17–22].
If samples are to be collected and used for research
purposes in Denmark, the research subject must be of
legal age (18 years) to voluntarily consent to participate.
If the research subject is not able to consent, for
example, due to the age, such authority lies with the
parents or the guardians [23]. If a research project
obtains significant information about the health status of
the research subject, the research subject should be
informed, unless the subject has specifically expressed
that s/he does not want the information [24]. The
Danish National Committee on Health Research Ethics
has developed a guideline on genomic research [25]. The
guideline addresses inclusion of children in genomic
research and return of incidental findings. It is empha-
sized that there must be a direct health benefit for the
individual child to justify inclusion in whole genome
research and that it is not sufficient to include children
simply to study the genetics of a disease. Return of
results to research subjects is only the norm for genetic
variants with high penetrance that predispose to serious
curable or treatable disease, whereas no return of results
is usually provided for genetic variants with low or mod-
erate penetrance and uncertain clinical significance [25].
The guideline furthermore addresses that exemptions
from obtaining consent from parents can be given if the
research project uses biological samples archived in a
biobank [25].
The legal regulations in Denmark on the return of
findings based on children’s DNA are complex and
unclear. This makes it difficult for researchers and
research subjects to navigate the regulations governing
the return of findings from children’s DNA. We assume
that the severity, treatability, and preventability of the
disease; the age of the child; and the decision on
whether to return incidental findings are discussed at
the time of donation of the sample as all these issues are
relevant in the decision-making. It is unclear whether
the return of genetic risk variants with high penetrance
that predispose to severe, curable, or treatable diseases
encompasses all known genetic risk variants, including
those for adult-onset disorders. Furthermore, it is
unclear if results should be returned to the child or to
the parents or whether results should be conveyed only
when the child reaches legal age.
Previous studies have found that parents generally
think that children should be involved in genomic
research and that parents have a right to know about
incidental findings concerning their child(ren) [26–28].
However, to our knowledge, no large studies have inves-
tigated the attitudes towards the involvement of children
in genomic research among potential research subjects.
Researching such attitudes is important to create policy
strategies and to design future genomic research projects
that meet the concerns and expectations of potential
research subjects. We chose to study this topic in the
context of mental disorders because they are some of
the commonest disorders in the population and because
large genome sequencing studies have been conducted
in this area [13, 29, 30].
This study aims to explore attitudes among stake-
holders in psychiatric genetic research towards (i) chil-
dren as genomic research subjects, (ii) return of
pertinent and incidental findings, and (iii) disclosure to
participants (i.e., children) or their parents.
Methods
For the purpose of this study, we use pertinent findings
for the results that are directly relevant to the condition
under investigation and incidental findings for results
that are not directly related to the research project but
may have health importance for the individual research
subject. We use a definition of childhood, starting from
birth to 18 years of age, referring to the legal age of
majority in Denmark. According to Statistics Denmark,
individuals under age 26 living at home are defined as
home-living children because the child has parental
reference to at least one adult [31]. Therefore, we define
a parent as a male or female with children under age
26 years living at home.
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Mixed-methods
We used a mixed-methods design as we collected both
qualitative and quantitative data [32]. This approach was
taken to address the overall aim at different levels and to
complement the strengths of a single-method design.
The motivation for using a mixed-methods design was
to use qualitative interviews to develop and modify the
quantitative survey, but the qualitative interviews also
helped to approach the field regarding inclusion of
children in genomic research from a different angle.
The qualitative interviews
The interviews were conducted to explore the attitudes
towards ethical issues regarding the use of genomic
sequencing in psychiatric research among experts
engaged in genomic research and among potential
research participants in psychiatric genetic research. The
interview guides were developed on the basis of relevant
literature and the research questions of the overall study.
The overall interview guides focused on attitudes towards
(i) sharing findings, (ii) consenting procedures, (iii) duties
of genomic researchers, (iv) including children in genomic
research, and (v) misuse of knowledge in genetics. All
interviews were conducted from 5 December 2012 to 11
December 2013, and each interview lasted between 30
and 90 min.
The informants
The informants in the interviews were experts (doctors
and nurses), working with issues surrounding genomic
research in Denmark, including the Faroe Islands, and
persons with schizophrenia. The informants in the focus
group interviews comprised persons with ADHD,
parents to children with ADHD, clinical geneticists, and
healthy controls (blood donors from the Danish Blood
Donor Study (DBDS)). The persons with schizophrenia
and ADHD were all diagnosed by psychiatrists and were
stable in daily life. All blood donors who participated in
the interview (and in the survey) are part of DBDS and
have all given a broad informed consent to participate in
a biobank for research and are potential healthy controls
in genomic research. To be included in DBDS, the individual
is not subjected to any medical treatment [33, 34]. Partici-
pants in the interview were all voluntary and informants
were recruited through direct email contact, paper flyers at
an activity center for mentally ill, invitations posted in an
ADHD Facebook group, an ADHD clinic, a psychiatrist
working in private practice, Copenhagen Hospital Biobank,
and a blood donor Facebook group.
The data analysis
All interviews were audio-recorded, transcribed verbatim,
coded, and analyzed using the software package NVivo 11
[35]. NVivo helped to organize and manage the data. We
were based on Grounded Theory as a method to analyze
the data because this analytical strategy suggests a systematic
analysis and enabled us to explore and identify attitudes
towards inclusion of children in genomic research [36]. All
transcripts were analyzed after a three-step process: open
coding, axial coding, and selective coding [36]. We
examined the emerging core concepts overall and how they
differed across informants. We used some of the core
concepts to develop items for the survey. For this paper, we
selected relevant and illustrative quotes regarding inclusion
of children in genome research and return of results. All
quotes were translated from Danish into English by a
professional translator.
The cross-sectional survey
After the interviews, we conducted a cross-sectional
web-based survey to explore specific attitudes towards
the use of genomic research in Denmark. The survey
was a translated and modified version of an English
web-based survey developed at the Wellcome Trust
Sanger Institute in Cambridge, UK [3, 37–40]. Details of
the development of both the English and Danish survey
versions have been presented elsewhere [39, 41]. On
basis of the qualitative interviews, we modified the
Danish version of the survey to also include items on
informed consent, inclusion of children, and personal
and familial experience with mental disorders. Items on
children in genomic research were included because it
was a key topic in the interviews and because the category
of “age” came up in all the interviews. The survey also
included self-reported sociodemographic information.
Ten explanatory video films with subtitles and voice-over
were used to illustrate the ethical issues raised in the
survey (https://svaros.dk/holdning). The data collection
began in August 2014 and ended April 2015. An average
survey took approximately 23 min to complete.
The stakeholders
Potential stakeholders in psychiatric genomic research
were recruited: (i) 241 persons with mental disorders
(who are potential cases in genomic research), (ii) 671
relatives to individuals with mental disorders (who are
potential controls in genomic research), (iii) 1623 blood
donors from DBDS (who serve as healthy controls in
genomic research) [33, 34], (iv) 28 clinical geneticists
(who analyze, return, and explain genomic data to
patients and relatives in their clinical work and who
must validate sequencing findings obtained in research),
and (v) 74 psychiatrists (who diagnose and treat people
with mental disorders) (N = 2637). We recruited the
stakeholders through email, paper flyers at psychiatric
hospitals, invitations posted in an ADHD Facebook
group, and links at the homepages of the Danish Psychiatric
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Association, the Danish Society of Medical Genetics, and
user groups of psychiatric patients and their relatives.
Statistical analysis
We expected parents to hold a different attitude from non-
parents because of their parenthood and interest in the
health of their child. For example, parents might be
motivated to participate in genomic research with the hope
of receiving crucial information about the health of their
child. Therefore, we decided to divide the stakeholders into
parents (persons with children under age 26 years living at
home) or non-parents (persons without children).
Descriptive statistics were used to characterize the study
sample. Unadjusted associations between items and
stakeholders were estimated using χ2 tests. Multivariable
logistic regression with 95% confidence interval (CI) and a
p value of 0.05 was used to estimate the association
between item and stakeholder adjusted for parenthood,
gender, age, educational level, marital status, and stake-
holder group. “Don’t know” answers were omitted from
the regression model but are a part of the analysis regarding
the questions towards the return of pertinent and incidental
finding in children (Figs. 1 and 2). The analysis of the data
was carried out using SAS® 9.4 [42].
The two questions regarding return of pertinent and in-
cidental findings from research could be answered in four
different ways, and respondents were allowed to choose
more than one answer. We analyzed all answers and iden-
tified six combinations for pertinent findings and the same
six combinations for incidental findings: (i) The child
should have the opportunity to get information about per-
tinent/incidental findings, (ii) The child should not have
Fig. 1 Flowchart of attitudes towards the return of pertinent findings to children or parents distributed on parents and non-parents, N and %
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the opportunity to get information about pertinent/inci-
dental findings from research, (iii) The parents should have
the opportunity to receive pertinent findings about the
child if they would like to receive such information,
(iv) The child should be of legal age before getting the
opportunity to receive pertinent/incidental findings, (v) The
child and the parents should have the opportunity to receive
pertinent/incidental findings, (vi) The parents and the child,
when of legal age (18 years), should have the opportunity to
receive pertinent/incidental findings (Figs. 1 and 2).
Results
The qualitative interviews
Sample characteristics
A total of 10 semi-structured qualitative interviews were
conducted in this study: four focus-group interviews, one
group interview, and five individual interviews. The infor-
mants consisted of 12 males and 17 females (Table 1).
Attitudes towards using children as genomic research subjects
The attitudes towards children as genomic research sub-
jects varied. Experts, persons with ADHD, and parents of
children with ADHD generally had a positive view, whereas
clinical geneticists, persons with schizophrenia, and blood
donors tended to have more ambiguous views. As a person
with schizophrenia expressed: “Children should not be part
of a research project, really. That makes a mess.”
The age of the child played a major role in the talks
and discussions about children as research subjects. The
overall attitudes were that parents should make the
decision on whether their child should be included or
not, that parents should give informed consent on behalf
Fig. 2 Flowchart of attitudes towards the return of incidental findings to children or parents distributed on parents and non-parents, N and %
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of their child, and that the child should be involved in
the decisions depending on the age of the child: the
older the child, the more the child should be involved in
the decision-making.
The willingness to enroll children in genomic research
was often associated with the dilemma of receiving the
individual results:
Is it fair to deny the child the right to receive this
knowledge [about genetic findings] from a research
project – to say yes or no regarding information
about himself or herself? […] I don’t think that we
should cancel the research, but I think that the
problem occurs when you start to involve the families
in the return of individual results. (Clinical geneticist)
During the interview with the clinical geneticists, the
discussion addressed the use of PKU samples in research
and two informants discussed use of their own children’s
archived neonatal PKU samples:
Clinical geneticist A, “My children, they should no
longer be registered in the Danish Neonatal Screening
Biobank. I will make the call next week.”
Clinical geneticist B, “What then if they become ill,
and you could have known it?”
Clinical geneticist A, “Yes. I know that.”
Clinical geneticist B concludes, “But it is exactly post-
rationalization that is difficult. I mean, beforehand, we
may say that we don’t want to know, but what then if
we suddenly have a sick child; and we could have done
something?”
The clinical geneticists discussed the return of individual
research results in relation to a child’s right to make an
autonomous decision, but the discussion also touched on
the possibility of using the research results as clinical
information with potential health benefits for their child.
Several informants agreed that there is an emotional
burden linked to the recipient’s age at the time when
information about such findings is received and that
returning the findings too early in the child’s life “could
ruin the person’s life.” (blood donor)
There is great difference between a man of 51, such as
myself, with certain life experience – both good and
bad – and a young person with certain ideas about how
hers life should be and who would be terribly disturbed
by knowing of an 80 percent risk of getting, for
example, breast cancer. So you have to consider when
in life you should [return knowledge about findings], I
think that is what I believe. (Other blood donor)
Some of the informants also expressed that there is an
emotional burden associated with the return of findings
to parents:
Well, I would say that neither I nor the children
should know anything before they have turned 18. I
really don’t think that the children can handle
knowledge about it at their age and I… I should
obviously not have that knowledge about my children
before they are 18. Because I cannot handle such
knowledge either. (Mother of a child with ADHD)
Nevertheless, there was no consensus among the
informants as to whether the parents or the child should
receive the findings:
There is no doubt that I love him, my son. I love him
more than anything, but I would still like to have that
knowledge because it is a hard life. (Father of a child
with ADHD)
The two parents of children with ADHD have different
attitudes to the return of findings from research. The
mother states that she should not receive the findings
until her child is of legal age, whereas the father focuses
on the opportunity to receive information that could
help his son get a better life.
In short, the attitudes towards children as genomic
research subjects varied among informants. There was no
consensus whether children should be genomic research
subjects and whether the child or the parents should
receive the genomic findings. The attitudes of involving
Table 1 Overview of sample characteristics in the qualitative
interviews
Interview Informants Supplementary information
Focus-group
interview
Persons with ADHD (n = 5) Male 4; female 1,
Denmark
Focus-group
interview
Parents to children with
ADHD (n = 6)
Male 1; female 5,
Denmark
Focus-group
interview
Danish blood donors from
DBDS (n = 5)
Male 3; female 2, Denmark
Focus-group
interview
Clinical geneticists (n = 6) Male 1; female 5, Denmark
Group
interview
Experts (n = 2) Females, Faroe Islands
Individual
interview
Expert Female, Faroe Islands
Individual
interview
Expert Male, Denmark
Individual
interview
Person with schizophrenia Female, Denmark
Individual
interview
Person with schizophrenia Male, Denmark
Individual
interview
Person with schizophrenia Male, Denmark
The table presents type of interview and background of informants, their gender,
and country of origin
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children in genomic research focused on the child’s right to
take an autonomic choice when of legal age, the emotional
burden of knowing of both children and parents, and the
possibility of receiving clinical information that could benefit
the future health of the child.
The survey
Sample characteristics
A total of 1227 parents and 1406 non-parents completed
the survey. Their characteristics are presented in Table 2.
There was an almost equal distribution between males
and females. Parents were significantly older than non-
parents. The mean age was 45 years (standard deviation
(SD) 8) for parents and 48 years (SD 15) for non-parents.
A higher proportion of parents than non-parents had a
long level of education and was married/cohabiting. The
majority of persons with mental disorders were diagnosed
with depression, anxiety, or obsessive compulsive disorder
by a doctor. The majority of relatives was first or second
degree relatives (data not shown). No statistically significant
differences were found for gender and stakeholder group
membership between parents and non-parents (Table 2).
Thus, parents were older, better educated (due to their
age), and—not surprisingly—married.
Attitudes towards children as research subjects
Table 3 shows the respondents’ attitudes towards
children as research subjects in genomic research and
the association with parenthood, age, educational level,
marital status, and stakeholder group.
Significantly more males (76%) than females (63%) and
significantly less persons with short higher education
(67%) and other education (61%) than persons with long
higher education responded that children should be able
to participate in genomic research.
A consistent finding was that parents were more positive
towards this statement than non-parents. Persons in the
young age group (20–40 years), the older age group
(61–76 years), single persons, persons with mental
disorders, psychiatrists, and clinical geneticists were more
negative towards the statement than persons in the mid
age group (41–60 years), persons in a partnership, and
blood donors (Table 3).
Attitudes towards the return of pertinent and incidental
findings in children
As shown in Table 3, a majority of parents and non-
parents responded that children should be able to partici-
pate in genomic research. However, 24% parents and 27%
non-parents responded that children should not be able to
participate in genomic research, whereas 15% parents and
17% non-parents did not know (Figs. 1 and 2).
The parents and non-parents who responded in the
survey that children should be able to participate in genomic
research (N = 1526) were asked about their opinion on the
return of pertinent and incidental findings (Figs. 1 and 2).
Firstly, both for pertinent (N = 1441) and incidental findings
(N = 1399), parents and non-parents agreed that the parents
should have the opportunity to receive both types of find-
ings. Secondly, the child should be of legal age before s/he
should be provided with the opportunity to receive pertinent
(N = 738) and incidental findings (N = 752).
Discussion
Main findings
Two main discussion points emerged from the study.
These will be discussed below.
Table 2 Socioeconomic characteristics of survey respondents
Parents
(n = 1227)
Non-parents
(n = 1406)
p value**
% (n*) % (n*)
Sex 0.37
Female 52 (634) 53 (751)
Male 48 (591) 47 (653)
Age groups, years < 0.0001
20–40 28 (347) 36 (504)
41–60 70 (852) 37 (526)
61–76 2 (25) 27 (373)
Age, mean (SD) 45 (8) 48 (15)
Level of high education*** < 0.0001
None higher education 2 (17) 3 (34)
Short higher(< 3 years) 28 (348) 29 (409)
Medium higher (3–4 years) 29 (356) 32 (449)
Long higher (> 4 years) 38 (470) 31 (439)
Other education 3 (35) 5 (74)
Marital status < 0.0001
Married/cohabiting 84 (1032) 52 (727)
Partnership 6 (70) 17 (241)
Single 10 (122) 31 (437)
Stakeholder groups 0.23
Persons with mental
disorders
8 (103) 10 (138)
Relatives to persons
with mental disorders
26 (322) 25 (348)
Blood donors 61 (749) 62 (871)
Clinical geneticists 2 (18) 1 (10)
Psychiatrists 3 (35) 2 (39)
Socio-economic characteristics of the sample; specified in percentage and
number of participants divided by parents, non-parents, and total. Values that
were significant at p < 0.05 are set in italics
*n varies because of missing data
**χ2
***Children must receive 10 years of compulsory education in Denmark
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Children as genomic research subjects
In a hypothetical scenario, participants are overall likely
to hold positive views on the question whether a child
should be able to participate in genomic research. Our
findings are similar to Fernandez et al. [26], who found
that the majority of participants reported that children
should be able to take part in genomic research, whether
the condition under study began in childhood or not
and independent of the existence of effective treatment.
We expected that parents in the survey would hold a
more positive view and that non-parents would be more
indifferent, but we found only slightly higher agreement
among parents than among non-parents.
There was a significant higher agreement towards
involving children in genomic research among males
than females indicating that males have less protective
or more chance-taking behaviors than females. Having
short higher education and other education was
significantly associated with less agreement toward
the statement than persons with long higher education.
Individuals with low level of education may have greater
difficulties in understanding the consequences of genomic
data and thus more worries of letting children participate
in genomic research.
Return of results: the child’s right to know
Participants expressed an attitude and also an expectation
towards receiving research findings concerning children.
In the interviews, there was no consensus whether the
child or the parents should receive the findings. However,
the return of findings were discussed in relation to the
child’s age, the child’s right to an autonomous choice, the
possibility of the emotional burden of knowing, and the
possibility of receiving important clinical information. The
majority in the survey agreed that both pertinent and
incidental findings should be returned to the parents and
to the child when of legal age. As parents might be more
interested than non-parents in receiving clinical information,
we expected that parents would take a more positive
approach than non-parents. Nevertheless, we found that
parents and non-parents had very similar attitudes. Thus,
having children does not seem to affect stakeholder’s
attitudes towards return of findings in children.
Furthermore, there were no differences in participant’s
attitudes towards the return of pertinent or incidental
findings, and they are interested in receiving both types
of findings regarding the child. Our results illustrate that
there are an interest in receiving information and that
the child’s right to an autonomous choice and the
parent’s interest to be informed are both important for
the participants. The results in the survey study are
consistent with those of Kleiderman et al. [28], who
found that parents of children affected by a wide range
of rare diseases expressed an interest in receiving their
child’s research results. However, our results further
illustrate that the guideline on genomic research from
The Danish National Committee on Health Research
Ethics [25] is more restrictive than participants’ attitudes
toward the inclusion of children in genomic research.
The participants accept inclusion of children in research
without having direct health benefit for the child,
including studies of the genetics of a disorder. Additionally,
they are more positive towards the return of findings than
the guideline.
Table 3 Attitudes towards children as research subjects in
genomic research
Do you think that children (up to age 18) should be able to participate
in genomic research?
N Yes % (n) OR adj (95% CI)* p value
Parenthood 2205
Non-parent 67 (776) 1.00
Parent 72 (750) 1.19 (0.96–1.48) 0.12
Sex 2204
Female 63 (714) 1.00
Male 76 (813) 1.77 (1.46–2.14) < 0.0001
Age groups, years 2202
41–60 70 (806) 1.00
20–40 69 (501) 0.95 (0.76–1.19) 0.67
61–76 68 (218) 0.92 (0.68–1.24) 0.58
Level of high education 2206
Long higher (> 4 years) 73 (562) 1.00
None higher education 60 (25) 0.54 (0.29–1.06) 0.07
Short higher (< 3 years) 67 (424) 0.75 (0.59–0.96) 0.03
Medium higher (3–4 years) 69 (456) 0.87 (0.68–1.11) 0.26
Other education 61 (60) 0.59 (0.38–0.93) 0.02
Marital status 2204
Married/cohabiting 70 (1034) 1.00
Partnership 70 (186) 1.09 (0.79–1.50) 0.62
Single 65 (305) 0.95 (0.75–1.22) 0.69
Stakeholder group 2207
Blood donors 70 (956) 1.00
Persons with mental
disorder
66 (130) 1.00 (0.73–1.39) 0.99
Relatives 70 (386) 1.05 (0.84–1.31) 0.69
Clinical geneticists 67 (18) 0.88 (0.40–2.12) 0.77
Psychiatrists 69 (38) 0.84 (047–1.59) 0.59
Multivariable logistic regression was used to assess the attitudes towards children
as research subjects in genomic research and the association with parenthood,
stakeholder group, gender, age, educational level, and marital status, with 95% CI
and p value of < 0.05. Values that were significant at p < 0.05 are set in italics
*Adjusted for parenthood, stakeholder group, gender, age, educational level,
and marital status
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Although the child does not have full autonomy when
joining a genomic research project, the child will have
autonomy in the future as an adult. As genomic research
may provide clinical findings about both child-onset and
adult-onset genetic diseases, it is important to consider
the child’s future and right to know and not to know.
Respecting the right to an open future means that the
child can make his or her own autonomous decisions
when reaching adulthood [10, 14, 27, 43, 44]. Feinberg
[45] holds that children have a right, while they still are
children, to remain ignorant of disease predisposition
until they reach adulthood, presumably capable of making
a well-informed decision. While the child is still a child,
these “future interests” include interests that the child will
in fact come to have in the future, including future interests
that might never happen [45]. The right to an open future
protects the child against having important life choices
determined by parents (and others) before having the ability
to make them for themselves. The parents can disrupt the
child’s right to an open future if they act in a way that will
cut off possibilities for the child in adulthood. For example,
if the parents receive findings regarding breast cancer
because of mutations in BRCA1 or BRCA2 genes, it can
conflict with the child’s right to an open future if knowledge
is disclosed that the child would have wanted to live
without as an adult. Nevertheless, withholding discoverable
information from the child could also close a child’s future
if the child were interested in receiving the information as a
child. The legal regulations in Denmark are unclear
whether the return of genomic results encompasses
adult-onset disorders and whether the results should
be returned to the child or to the parents. Thus, it is
uncertain whether parents have a right to be informed
about all their child’s genomic research findings,
including adult-onset genetic diseases. The Clinical
Sequencing Exploratory Research (CSER) Consortium
and the Electronic Medical Records and Genomics
(eMERGE) Network aim to develop practical strategies
for addressing questions concerning the return of
results in genomic research [44]. For example, CSER
and eMERGE address whether adult-onset findings
should be offered for pediatric research participants.
They conclude that, during the consent process, the
parents should be offered the choice of whether or not
to have the adult-onset actionable incidental findings
returned along with counseling [44]. In the Danish
clinical setting, children are not being offered genetic
testing for adult-onset conditions. However, the Danish
legislation in this area is unclear concerning the
research setting. The results of this study suggest that
it is important to incorporate the child’s right to an
open future and to address the return of information
of adult-onset genetic diseases in the (legal) discussion
of children as research subjects.
Strengths and limitations
It is a strength of the study design that we used both
interview and survey data because the two methods
contribute different insights to the topic. The interviews
provided an in-depth perspective concerning the
attitudes and views of the informants, and the survey
data provided a broader and more general attitudinal
perspective. It is also a strength that the first part of our
data collection was used to inform the second part as
the qualitative interviews inspired us to include
additional items in the questionnaire survey to focus its
scope. In the survey, we were measuring genomic
research broadly and not specific at psychiatric genomic
research. However, no larger studies have investigated
the attitudes of patients, relatives, and health profes-
sionals in psychiatry and genetics towards inclusion of
children in genomic research. The results illustrate that
persons with mental disorder and relatives do not differ
in attitudes from blood donors or clinical geneticists.
This study thus contributes with new original knowledge
in relation to stakeholders in psychiatry in Denmark.
Each mode of the data collection provided preferential
access to certain parts of the population. It is a strength
that we used web-based survey since this method is
known to recruit hard-to-reach groups [46, 47]. At the
same time, using a web-based survey requires the
participants to be familiar and have access to smart-
phones, tables, laptops, or computers, and this may
have excluded potential participants without these skills
or without access to such technical equipment or to the
internet. Therefore, it is likely that the included stake-
holders comprise a more homogeneous group, more
positive of genomic research than potential participants
who did not participate.
The study had some further limitations. Firstly, the sur-
vey and interviews had the inherent weaknesses of meas-
uring hypothetical scenarios as the participants did not
have direct experience with genomic research. “Real”
requests to use children in genomic research could produce
different results. Responses to hypothetical scenarios often
anticipate behaviors and future intentions rather than
actual behavior [48]. Therefore, studies are needed to test
actual behavior in a real-life situation. However, we still
think hypothetical scenario methodology is an important
tool for predicting interest in research and to understand
attitudes. Secondly, participants were included on a
voluntary basis, and we cannot assess the effects of non-
response. Participants may be more favorably inclined
towards genomic research than the general population
since the participants must be willing to take part in this
study and thereby have an influence on the generalizability
of the study results. The survey might have been too diffi-
cult or too long to maintain the engagement of the partici-
pants. This potential selection bias could mean that the
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results do not represent all possible stakeholders in
genomic research in Denmark. Thirdly, persons with
schizophrenia are difficult to recruit into trials [49]. In
this study, it was difficult to recruit persons with
schizophrenia to a focus-group interview. As a result,
we decided to conduct individual interviews in this
group of informants. A focus-group interview allows
for interaction between the informants and may have
given some more knowledge about the mechanisms
behind certain attitudes expressed by the informants.
Furthermore, it is possible that other core concepts
would have emerged including persons with different
mental disorders and psychiatrists because it is not
certain that the focus-group interview went to
saturation with the included interviews. Fourthly, we
used a broad age category of children in the survey. As
the age of the child could influence the participant’s
attitudes, it is important to divide the children into
several age categories in future studies. Fifthly, the
participants were not specifically recruited because of
their status as parents or non-parents. Instead, in
consideration of the overall aim, we focused on recruiting
a wide range of stakeholders in psychiatric genomic
research: persons with mental disorders, relatives, blood
donors, psychiatrists, and clinical geneticists. Finally, it
could have been interesting to study the participants’
attitudes towards the return of pertinent and incidental
findings in children subdivided into childhood-onset and
adult-onset diseases.
Conclusion
Participants generally reported positive views on the
inclusion of children in genomic research. Additionally,
our results illustrate that both the child’s right to
autonomy and the parent’s interest in receiving information
are important and valuable factors for the participants.
They hold more positive and comprehensive views than the
current Danish Guidelines on the inclusion of children and
return of findings. However, having children does not affect
the participant’s attitudes towards the inclusion of children
as research subjects in genomic research.
Genomic research on children raises complex ethical
issues and it is important to consider the view of
potential stakeholders who rarely get a voice. Despite
the Danish Guidelines, the issue of when to include
children as research subjects and how to deliver research
findings is still unclear and subject to legal challenges.
We hope that sharing their attitudes will help the
mobilization of knowledge on children as genomic
research subjects, the return of findings regarding adult-
onset genetic diseases, and the children’s right to an
open future. Similarly, we think it is important to
address these issues in the legal discussion of children as
research subjects.
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